Picture of Win-Partners Co logo

3183 Win-Partners Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-0.79%
3m+9.06%
6m+3.22%
1yr-7.56%
Volume Change (%)
10d/3m+4.42%
Price vs... (%)
52w High-7.89%
50d MA+6.79%
200d MA+3.44%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.58
Price to Tang. Book1.61
Price to Free Cashflow13.91
Price to Sales0.45
EV to EBITDA5.79

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.76%
Return on Equity8.82%
Operating Margin3.51%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue¥m64,537.8762,123.9466,391.9470,854.4777,064.19n/an/a2.01%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-22.45-17.66+22.9-8.05+5.33n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Win-Partners Co EPS forecast chart

Profile Summary

WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.

Directors

Last Annual
March 31st, 2024
Last Interim
June 30th, 2024
Incorporated
April 1st, 2013
Public Since
April 1st, 2013
No. of Shareholders
23,448
No. of Employees
629
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
28,559,236

3183 Share Price Performance

Upcoming Events for 3183

Q2 2025 Win-Partners Co Ltd Earnings Release

Q3 2025 Win-Partners Co Ltd Earnings Release

Dividend For 3183.T - 51.0000 JPY

Similar to 3183

Picture of Alfresa Holdings logo

Alfresa Holdings

jp flag iconTokyo Stock Exchange

Picture of Asahi Intecc Co logo

Asahi Intecc Co

jp flag iconTokyo Stock Exchange

Picture of Aso International logo

Aso International

jp flag iconTokyo Stock Exchange

Picture of As One logo

As One

jp flag iconTokyo Stock Exchange

Picture of Atect logo

Atect

jp flag iconTokyo Stock Exchange

FAQ